Resistance to initial therapy for patients with CLL may limit treatment options; however, rituximab combined with the PI3K inhibitor idelalisib may offer a tolerable alternative therapy.
"Serial killer" T cells produce sustained responses in patients with leukemia.
Autophagy inhibition may prove to be a valuable tool for overcoming TKI resistance when treating chronic myeloid leukemia.
This fact sheet offers tips to help patients with chronic myelogenous leukemia overcome challenges to adhering to treatment regimens.
Patients with CML may need help sorting through treatment options, managing side effects, and finding financial aid. This fact sheet is designed to offer support in these areas.
This fact sheet educates patients about what causes chronic myelogenous leukemia (CML) and how it can be treated.
This fact sheet explains myelofibrosis, treatment options, and quality of life issues to help patients and their loved ones cope with a diagnosis.
These tips can help patients with multiple myeloma learn more about how to cope with the disease.
A 23-year-old patient with Hodgkin lymphoma was seen as an inpatient consultation for a pruritic rash that had been present ...
By Justin M. Watts, MD; Peter Maslak, MD; Martin S. Tallman, MD
A 47-year-old woman presented for evaluation of pancytopenia. She ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|